u 74389f has been researched along with Nerve Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagetta, G; Iannone, M; Nisticó, G; Rispoli, V; Rotiroti, D; Vecchio, I | 1 |
| Clement, HW; Grote, C; Jellinger, K; Mennel, HD; Nafe, R; Riederer, P; Solbach, M; Sontag, KH; Wesemann, W | 1 |
| Camarata, PJ; Heros, RC; Kondoh, T; Lee, SH | 1 |
3 other study(ies) available for u 74389f and Nerve Degeneration
| Article | Year |
|---|---|
Neurodegeneration produced by intrahippocampal injection of paraquat is reduced by systemic administration of the 21-aminosteroid U74389F in rats.
Topics: Animals; Antioxidants; Free Radicals; Hippocampus; Male; Motor Activity; Nerve Degeneration; Nervous System Diseases; Paraquat; Pregnatrienes; Rats; Rats, Wistar; Seizures | 1994 |
Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Dopamine; Injections; Iron; Lipid Peroxidation; Male; Microelectrodes; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease, Secondary; Pregnatrienes; Rats; Rats, Wistar; Substantia Nigra | 1995 |
Therapeutic time window for the 21-aminosteroid, U-74389G, in global cerebral ischemia.
Topics: Animals; Antioxidants; Brain; Brain Ischemia; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intraperitoneal; Ischemic Attack, Transient; Nerve Degeneration; Pregnatrienes; Rats; Rats, Wistar; Reperfusion Injury | 1996 |